filmov
tv
Darren McGuire | Cardiovascular effects of diabetes medications: Lessons learned from CVOTs
Показать описание
Texas Heart Institute Cardiology Grand Rounds. September 14, 2018.
Dr. Darren McGuire reviews the evolution of the regulatory requirements for drugs for type 2 diabetes, the key findings from CV outcome trials completed to date and selected potential mechanisms underpinning beneficial effects of SGLT2 inhibitors on CV mortality and heart failure risk.
Dr. Darren McGuire reviews the evolution of the regulatory requirements for drugs for type 2 diabetes, the key findings from CV outcome trials completed to date and selected potential mechanisms underpinning beneficial effects of SGLT2 inhibitors on CV mortality and heart failure risk.
0:46:40
0:45:57
0:18:05
0:08:26
0:02:33
0:03:11
1:13:52
0:25:17
0:26:07
0:02:09
0:00:59
0:00:42
0:03:40
0:05:09
1:37:05
0:00:54
0:00:40
0:50:30
0:16:30
0:13:49
2:36:55
0:18:10
0:07:34
0:23:21